Drug Profile
Diclofenac rectal - CeNeS
Alternative Names: Diclofenac Hycore-RLatest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator CeNeS Pharmaceuticals
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postoperative pain
Most Recent Events
- 12 Sep 2002 Discontinued - Phase-I for Postoperative pain in United Kingdom (Rectal)
- 16 Dec 1999 Core Group has merged with CeNeS Limited to form CeNeS Pharmaceuticals
- 30 Apr 1998 Phase-I clinical trials for Postoperative pain in United Kingdom (Rectal)